Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marco Vitoria

Showing results (11-20 of 91) with videos related to

Pageof 10
Sort By:
AIDS (London, England)|December 1, 2021
Optimizing switching strategies to simplify antiretroviral therapy: the future of second-line from a public health perspectiveEmmanuelle Papot, Richard Kaplan, Marco Vitoria, et al.
Current Opinion in HIV and AIDS|January 31, 2017
Diagnosis and monitoring of HIV programmes to support treatment initiation and follow up and improve programme qualityWillem Daniel Francois Venter, Nathan Ford, Marco Vitoria, et al.
Current Opinion in HIV and AIDS|October 9, 2013
Optimization and simplification of antiretroviral therapy for adults and childrenNathan Ford, Charles Flexner, Stefano Vella, et al.
Current Opinion in HIV and AIDS|October 9, 2013
The 2013 WHO guidelines for antiretroviral therapy: evidence-based recommendations to face new epidemic realitiesMeg Doherty, Nathan Ford, Marco Vitoria, et al.
Current Opinion in HIV and AIDS|June 5, 2020
Global public health efforts to address HIV and related communicable disease syndemicsNathan Ford, Teodora Wi, Philippa Easterbrook, et al.
Current Opinion in HIV and AIDS|January 7, 2017
The evolving role of CD4 cell counts in HIV careNathan Ford, Graeme Meintjes, Marco Vitoria, et al.
The Lancet. HIV|June 8, 2025
Retiring the language of first-line and second-line ARTMarco Vitoria, Graeme Meintjes, Nathan Ford, et al.
Current Opinion in HIV and AIDS|April 15, 2017
When could new antiretrovirals be recommended for national treatment programmes in low-income and middle-income countries: results of a WHO Think TankMarco Vitoria, Nathan Ford, Polly Clayden, et al.
Lancet (London, England)|December 4, 2009
New WHO HIV treatment and prevention guidelinesSiobhan Crowley, Nigel Rollins, Nathan Shaffer, et al.
Journal of the International AIDS Society|April 16, 2020
Systematic review of the efficacy and safety of antiretroviral drugs against SARS, MERS or COVID-19: initial assessmentNathan Ford, Marco Vitoria, Ajay Rangaraj, et al.
Pageof 10

Showing results (11-20 of 91) with videos related to

Sort By:
Pageof 10
AIDS (London, England)|December 1, 2021
Optimizing switching strategies to simplify antiretroviral therapy: the future of second-line from a public health perspectiveEmmanuelle Papot, Richard Kaplan, Marco Vitoria, et al.
Current Opinion in HIV and AIDS|January 31, 2017
Diagnosis and monitoring of HIV programmes to support treatment initiation and follow up and improve programme qualityWillem Daniel Francois Venter, Nathan Ford, Marco Vitoria, et al.
Current Opinion in HIV and AIDS|October 9, 2013
Optimization and simplification of antiretroviral therapy for adults and childrenNathan Ford, Charles Flexner, Stefano Vella, et al.
Current Opinion in HIV and AIDS|October 9, 2013
The 2013 WHO guidelines for antiretroviral therapy: evidence-based recommendations to face new epidemic realitiesMeg Doherty, Nathan Ford, Marco Vitoria, et al.
Current Opinion in HIV and AIDS|June 5, 2020
Global public health efforts to address HIV and related communicable disease syndemicsNathan Ford, Teodora Wi, Philippa Easterbrook, et al.
Current Opinion in HIV and AIDS|January 7, 2017
The evolving role of CD4 cell counts in HIV careNathan Ford, Graeme Meintjes, Marco Vitoria, et al.
The Lancet. HIV|June 8, 2025
Retiring the language of first-line and second-line ARTMarco Vitoria, Graeme Meintjes, Nathan Ford, et al.
Current Opinion in HIV and AIDS|April 15, 2017
When could new antiretrovirals be recommended for national treatment programmes in low-income and middle-income countries: results of a WHO Think TankMarco Vitoria, Nathan Ford, Polly Clayden, et al.
Lancet (London, England)|December 4, 2009
New WHO HIV treatment and prevention guidelinesSiobhan Crowley, Nigel Rollins, Nathan Shaffer, et al.
Journal of the International AIDS Society|April 16, 2020
Systematic review of the efficacy and safety of antiretroviral drugs against SARS, MERS or COVID-19: initial assessmentNathan Ford, Marco Vitoria, Ajay Rangaraj, et al.
Pageof 10